WHO Concerned About Rise in COVID Hospitalisation But Lacks Data From Member States 06/09/2023 Kerry Cullinan There are “concerning trends for COVID-19 ahead of the winter season in the northern hemisphere”, including increased ICU admissions and hospitalisation in Europe, and case increases in the Middle East and Asia, according to World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus. However, the WHO’s ability to assess the threat of new COVID-19 variants […] Continue reading -> ‘Bullying’ Pharma Giants Charged South Africa More Than EU for COVID-19 Vaccines 05/09/2023 Kerry Cullinan Pharmaceutical giant Janssen/Johnson & Johnson (J&J) and generic manufacturer Serum Institute of India (SII) charged the South African government more than the European Union for COVID-19 vaccines – and South Africa assumed all the risk in ‘take-it-or-leave-it’ contracts with Pfizer, J&J and SII. This is according to an analysis of the contracts led by Health […] Continue reading -> UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Bullying’ Pharma Giants Charged South Africa More Than EU for COVID-19 Vaccines 05/09/2023 Kerry Cullinan Pharmaceutical giant Janssen/Johnson & Johnson (J&J) and generic manufacturer Serum Institute of India (SII) charged the South African government more than the European Union for COVID-19 vaccines – and South Africa assumed all the risk in ‘take-it-or-leave-it’ contracts with Pfizer, J&J and SII. This is according to an analysis of the contracts led by Health […] Continue reading -> UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts